Global Anticoagulants Market by Manufacturers, Regions, Type and Application, Forecast to 2023

Publisher Name :
Date: 11-Jul-2018
No. of pages: 132

Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, serum-separating tubes, blood transfusion bags, and dialysis equipment.

Scope of the Report:

This report focuses on the Anticoagulants in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, serum-separating tubes, blood transfusion bags, and dialysis equipment.

Anticoagulants are widely used for VTE, ACS/MI, AF and other field. The most proportion of anticoagulants used to treat AF, and the revenue in 2016 is 13118 M USD.

Europe region is the largest supplier of anticoagulants, with a production market share nearly 56.40% in 2016. North America is the second largest supplier of anticoagulants, enjoying production market share nearly 26.35% in 2016.

The worldwide market for Anticoagulants is expected to grow at a CAGR of roughly 8.8% over the next five years, will reach 1230 million US$ in 2023, from 740 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- Sanofi

- Bayer

- Boehringer Ingelheim

- Johnson & Johnson

- Genentech (Roche)

- AstraZeneca

- Bristol-Myers Squibb

- Aspen

- Lilly

- Otsuka

- Pfizer

- Daiichi Sankyo

- The Medicines Company

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Platelet aggregation inhibitors (PAI)

- Low-molecular-weight Heparin (LMWH)

- Direct thrombin inhibitor (DTI)

- Direct factor Xa inhibitors (DFXa)

- Vitamin K antagonists (VKA)

- Others

Market Segment by Applications, can be divided into

- VTE

- ACS/MI

- AF

- Other

There are 15 Chapters to deeply display the global Anticoagulants market.

Chapter 1, to describe Anticoagulants Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Anticoagulants, with sales, revenue, and price of Anticoagulants, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Anticoagulants, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Anticoagulants market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Anticoagulants sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global Anticoagulants Market by Manufacturers, Regions, Type and Application, Forecast to 2023

Table of Contents

1 Market Overview
1.1 Anticoagulants Introduction
1.2 Market Analysis by Type
1.2.1 Platelet aggregation inhibitors (PAI)
1.2.2 Low-molecular-weight Heparin (LMWH)
1.2.3 Direct thrombin inhibitor (DTI)
1.2.4 Direct factor Xa inhibitors (DFXa)
1.2.5 Vitamin K antagonists (VKA)
1.2.6 Others
1.3 Market Analysis by Applications
1.3.1 VTE
1.3.2 ACS/MI
1.3.3 AF
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Business Overview
2.1.2 Anticoagulants Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Sanofi Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Bayer
2.2.1 Business Overview
2.2.2 Anticoagulants Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bayer Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Boehringer Ingelheim
2.3.1 Business Overview
2.3.2 Anticoagulants Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Boehringer Ingelheim Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Johnson & Johnson
2.4.1 Business Overview
2.4.2 Anticoagulants Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Johnson & Johnson Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Genentech (Roche)
2.5.1 Business Overview
2.5.2 Anticoagulants Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Genentech (Roche) Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 AstraZeneca
2.6.1 Business Overview
2.6.2 Anticoagulants Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 AstraZeneca Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Bristol-Myers Squibb
2.7.1 Business Overview
2.7.2 Anticoagulants Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Bristol-Myers Squibb Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Aspen
2.8.1 Business Overview
2.8.2 Anticoagulants Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Aspen Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Lilly
2.9.1 Business Overview
2.9.2 Anticoagulants Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Lilly Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Otsuka
2.10.1 Business Overview
2.10.2 Anticoagulants Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Otsuka Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Pfizer
2.11.1 Business Overview
2.11.2 Anticoagulants Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Pfizer Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Daiichi Sankyo
2.12.1 Business Overview
2.12.2 Anticoagulants Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Daiichi Sankyo Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 The Medicines Company
2.13.1 Business Overview
2.13.2 Anticoagulants Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 The Medicines Company Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Anticoagulants Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Anticoagulants Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Anticoagulants Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Anticoagulants Manufacturer Market Share in 2017
3.3.2 Top 6 Anticoagulants Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Anticoagulants Market Analysis by Regions
4.1 Global Anticoagulants Sales, Revenue and Market Share by Regions
4.1.1 Global Anticoagulants Sales and Market Share by Regions (2013-2018)
4.1.2 Global Anticoagulants Revenue and Market Share by Regions (2013-2018)
4.2 North America Anticoagulants Sales and Growth Rate (2013-2018)
4.3 Europe Anticoagulants Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Anticoagulants Sales and Growth Rate (2013-2018)
4.5 South America Anticoagulants Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Anticoagulants Sales and Growth Rate (2013-2018)
5 North America Anticoagulants by Countries
5.1 North America Anticoagulants Sales, Revenue and Market Share by Countries
5.1.1 North America Anticoagulants Sales and Market Share by Countries (2013-2018)
5.1.2 North America Anticoagulants Revenue and Market Share by Countries (2013-2018)
5.2 United States Anticoagulants Sales and Growth Rate (2013-2018)
5.3 Canada Anticoagulants Sales and Growth Rate (2013-2018)
5.4 Mexico Anticoagulants Sales and Growth Rate (2013-2018)
6 Europe Anticoagulants by Countries
6.1 Europe Anticoagulants Sales, Revenue and Market Share by Countries
6.1.1 Europe Anticoagulants Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Anticoagulants Revenue and Market Share by Countries (2013-2018)
6.2 Germany Anticoagulants Sales and Growth Rate (2013-2018)
6.3 UK Anticoagulants Sales and Growth Rate (2013-2018)
6.4 France Anticoagulants Sales and Growth Rate (2013-2018)
6.5 Russia Anticoagulants Sales and Growth Rate (2013-2018)
6.6 Italy Anticoagulants Sales and Growth Rate (2013-2018)
7 Asia-Pacific Anticoagulants by Countries
7.1 Asia-Pacific Anticoagulants Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Anticoagulants Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Anticoagulants Revenue and Market Share by Countries (2013-2018)
7.2 China Anticoagulants Sales and Growth Rate (2013-2018)
7.3 Japan Anticoagulants Sales and Growth Rate (2013-2018)
7.4 Korea Anticoagulants Sales and Growth Rate (2013-2018)
7.5 India Anticoagulants Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Anticoagulants Sales and Growth Rate (2013-2018)
8 South America Anticoagulants by Countries
8.1 South America Anticoagulants Sales, Revenue and Market Share by Countries
8.1.1 South America Anticoagulants Sales and Market Share by Countries (2013-2018)
8.1.2 South America Anticoagulants Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Anticoagulants Sales and Growth Rate (2013-2018)
8.3 Argentina Anticoagulants Sales and Growth Rate (2013-2018)
8.4 Colombia Anticoagulants Sales and Growth Rate (2013-2018)
9 Middle East and Africa Anticoagulants by Countries
9.1 Middle East and Africa Anticoagulants Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Anticoagulants Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Anticoagulants Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Anticoagulants Sales and Growth Rate (2013-2018)
9.3 UAE Anticoagulants Sales and Growth Rate (2013-2018)
9.4 Egypt Anticoagulants Sales and Growth Rate (2013-2018)
9.5 Nigeria Anticoagulants Sales and Growth Rate (2013-2018)
9.6 South Africa Anticoagulants Sales and Growth Rate (2013-2018)
10 Global Anticoagulants Market Segment by Type
10.1 Global Anticoagulants Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Anticoagulants Sales and Market Share by Type (2013-2018)
10.1.2 Global Anticoagulants Revenue and Market Share by Type (2013-2018)
10.2 Platelet aggregation inhibitors (PAI) Sales Growth and Price
10.2.1 Global Platelet aggregation inhibitors (PAI) Sales Growth (2013-2018)
10.2.2 Global Platelet aggregation inhibitors (PAI) Price (2013-2018)
10.3 Low-molecular-weight Heparin (LMWH) Sales Growth and Price
10.3.1 Global Low-molecular-weight Heparin (LMWH) Sales Growth (2013-2018)
10.3.2 Global Low-molecular-weight Heparin (LMWH) Price (2013-2018)
10.4 Direct thrombin inhibitor (DTI) Sales Growth and Price
10.4.1 Global Direct thrombin inhibitor (DTI) Sales Growth (2013-2018)
10.4.2 Global Direct thrombin inhibitor (DTI) Price (2013-2018)
10.5 Direct factor Xa inhibitors (DFXa) Sales Growth and Price
10.5.1 Global Direct factor Xa inhibitors (DFXa) Sales Growth (2013-2018)
10.5.2 Global Direct factor Xa inhibitors (DFXa) Price (2013-2018)
10.6 Vitamin K antagonists (VKA) Sales Growth and Price
10.6.1 Global Vitamin K antagonists (VKA) Sales Growth (2013-2018)
10.6.2 Global Vitamin K antagonists (VKA) Price (2013-2018)
10.7 Others Sales Growth and Price
10.7.1 Global Others Sales Growth (2013-2018)
10.7.2 Global Others Price (2013-2018)
11 Global Anticoagulants Market Segment by Application
11.1 Global Anticoagulants Sales Market Share by Application (2013-2018)
11.2 VTE Sales Growth (2013-2018)
11.3 ACS/MI Sales Growth (2013-2018)
11.4 AF Sales Growth (2013-2018)
11.5 Other Sales Growth (2013-2018)
12 Anticoagulants Market Forecast (2018-2023)
12.1 Global Anticoagulants Sales, Revenue and Growth Rate (2018-2023)
12.2 Anticoagulants Market Forecast by Regions (2018-2023)
12.2.1 North America Anticoagulants Market Forecast (2018-2023)
12.2.2 Europe Anticoagulants Market Forecast (2018-2023)
12.2.3 Asia-Pacific Anticoagulants Market Forecast (2018-2023)
12.2.4 South America Anticoagulants Market Forecast (2018-2023)
12.2.5 Middle East and Africa Anticoagulants Market Forecast (2018-2023)
12.3 Anticoagulants Market Forecast by Type (2018-2023)
12.3.1 Global Anticoagulants Sales Forecast by Type (2018-2023)
12.3.2 Global Anticoagulants Market Share Forecast by Type (2018-2023)
12.4 Anticoagulants Market Forecast by Application (2018-2023)
12.4.1 Global Anticoagulants Sales Forecast by Application (2018-2023)
12.4.2 Global Anticoagulants Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Anticoagulants Picture
Table Product Specifications of Anticoagulants
Figure Global Sales Market Share of Anticoagulants by Types in 2017
Table Anticoagulants Types for Major Manufacturers
Figure Platelet aggregation inhibitors (PAI) Picture
Figure Low-molecular-weight Heparin (LMWH) Picture
Figure Direct thrombin inhibitor (DTI) Picture
Figure Direct factor Xa inhibitors (DFXa) Picture
Figure Vitamin K antagonists (VKA) Picture
Figure Others Picture
Figure Anticoagulants Sales Market Share by Applications in 2017
Figure VTE Picture
Figure ACS/MI Picture
Figure AF Picture
Figure Other Picture
Figure United States Anticoagulants Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Anticoagulants Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Anticoagulants Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Anticoagulants Revenue (Value) and Growth Rate (2013-2023)
Figure France Anticoagulants Revenue (Value) and Growth Rate (2013-2023)
Figure UK Anticoagulants Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Anticoagulants Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Anticoagulants Revenue (Value) and Growth Rate (2013-2023)
Figure China Anticoagulants Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Anticoagulants Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Anticoagulants Revenue (Value) and Growth Rate (2013-2023)
Figure India Anticoagulants Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Anticoagulants Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Anticoagulants Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Anticoagulants Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Anticoagulants Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Anticoagulants Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Anticoagulants Revenue (Value) and Growth Rate (2013-2023)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Anticoagulants Type and Applications
Table Sanofi Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Anticoagulants Type and Applications
Table Bayer Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim Anticoagulants Type and Applications
Table Boehringer Ingelheim Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Anticoagulants Type and Applications
Table Johnson & Johnson Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Genentech (Roche) Basic Information, Manufacturing Base and Competitors
Table Genentech (Roche) Anticoagulants Type and Applications
Table Genentech (Roche) Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Anticoagulants Type and Applications
Table AstraZeneca Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Anticoagulants Type and Applications
Table Bristol-Myers Squibb Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Aspen Basic Information, Manufacturing Base and Competitors
Table Aspen Anticoagulants Type and Applications
Table Aspen Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Lilly Basic Information, Manufacturing Base and Competitors
Table Lilly Anticoagulants Type and Applications
Table Lilly Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Otsuka Basic Information, Manufacturing Base and Competitors
Table Otsuka Anticoagulants Type and Applications
Table Otsuka Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Anticoagulants Type and Applications
Table Pfizer Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table Daiichi Sankyo Anticoagulants Type and Applications
Table Daiichi Sankyo Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table The Medicines Company Basic Information, Manufacturing Base and Competitors
Table The Medicines Company Anticoagulants Type and Applications
Table The Medicines Company Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Anticoagulants Sales by Manufacturer (2016-2017)
Figure Global Anticoagulants Sales Market Share by Manufacturer in 2016
Figure Global Anticoagulants Sales Market Share by Manufacturer in 2017
Table Global Anticoagulants Revenue by Manufacturer (2016-2017)
Figure Global Anticoagulants Revenue Market Share by Manufacturer in 2016
Figure Global Anticoagulants Revenue Market Share by Manufacturer in 2017
Figure Top 3 Anticoagulants Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Anticoagulants Manufacturer (Revenue) Market Share in 2017
Figure Global Anticoagulants Sales and Growth Rate (2013-2018)
Figure Global Anticoagulants Revenue and Growth Rate (2013-2018)
Table Global Anticoagulants Sales by Regions (2013-2018)
Table Global Anticoagulants Sales Market Share by Regions (2013-2018)
Table Global Anticoagulants Revenue by Regions (2013-2018)
Figure Global Anticoagulants Revenue Market Share by Regions in 2013
Figure Global Anticoagulants Revenue Market Share by Regions in 2017
Figure North America Anticoagulants Sales and Growth Rate (2013-2018)
Figure Europe Anticoagulants Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Anticoagulants Sales and Growth Rate (2013-2018)
Figure South America Anticoagulants Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Anticoagulants Sales and Growth Rate (2013-2018)
Figure North America Anticoagulants Revenue and Growth Rate (2013-2018)
Table North America Anticoagulants Sales by Countries (2013-2018)
Table North America Anticoagulants Sales Market Share by Countries (2013-2018)
Figure North America Anticoagulants Sales Market Share by Countries in 2013
Figure North America Anticoagulants Sales Market Share by Countries in 2017
Table North America Anticoagulants Revenue by Countries (2013-2018)
Table North America Anticoagulants Revenue Market Share by Countries (2013-2018)
Figure North America Anticoagulants Revenue Market Share by Countries in 2013
Figure North America Anticoagulants Revenue Market Share by Countries in 2017
Figure United States Anticoagulants Sales and Growth Rate (2013-2018)
Figure Canada Anticoagulants Sales and Growth Rate (2013-2018)
Figure Mexico Anticoagulants Sales and Growth Rate (2013-2018)
Figure Europe Anticoagulants Revenue and Growth Rate (2013-2018)
Table Europe Anticoagulants Sales by Countries (2013-2018)
Table Europe Anticoagulants Sales Market Share by Countries (2013-2018)
Table Europe Anticoagulants Revenue by Countries (2013-2018)
Figure Europe Anticoagulants Revenue Market Share by Countries in 2016
Figure Europe Anticoagulants Revenue Market Share by Countries in 2017
Figure Germany Anticoagulants Sales and Growth Rate (2013-2018)
Figure UK Anticoagulants Sales and Growth Rate (2013-2018)
Figure France Anticoagulants Sales and Growth Rate (2013-2018)
Figure Russia Anticoagulants Sales and Growth Rate (2013-2018)
Figure Italy Anticoagulants Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Anticoagulants Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Anticoagulants Sales by Countries (2013-2018)
Table Asia-Pacific Anticoagulants Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Anticoagulants Sales Market Share by Countries 2017
Table Asia-Pacific Anticoagulants Revenue by Countries (2013-2018)
Figure Asia-Pacific Anticoagulants Revenue Market Share by Countries 2017
Figure China Anticoagulants Sales and Growth Rate (2013-2018)
Figure Japan Anticoagulants Sales and Growth Rate (2013-2018)
Figure Korea Anticoagulants Sales and Growth Rate (2013-2018)
Figure India Anticoagulants Sales and Growth Rate (2013-2018)
Figure Southeast Asia Anticoagulants Sales and Growth Rate (2013-2018)
Figure South America Anticoagulants Revenue and Growth Rate (2013-2018)
Table South America Anticoagulants Sales by Countries (2013-2018)
Table South America Anticoagulants Sales Market Share by Countries (2013-2018)
Figure South America Anticoagulants Sales Market Share by Countries in 2017
Table South America Anticoagulants Revenue by Countries (2013-2018)
Table South America Anticoagulants Revenue Market Share by Countries (2013-2018)
Figure South America Anticoagulants Revenue Market Share by Countries in 2017
Figure Brazil Anticoagulants Sales and Growth Rate (2013-2018)
Figure Argentina Anticoagulants Sales and Growth Rate (2013-2018)
Figure Colombia Anticoagulants Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Anticoagulants Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Anticoagulants Sales by Countries (2013-2018)
Table Middle East and Africa Anticoagulants Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Anticoagulants Sales Market Share by Countries in 2017
Table Middle East and Africa Anticoagulants Revenue by Countries (2013-2018)
Table Middle East and Africa Anticoagulants Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Anticoagulants Revenue Market Share by Countries in 2013
Figure Middle East and Africa Anticoagulants Revenue Market Share by Countries in 2017
Figure Saudi Arabia Anticoagulants Sales and Growth Rate (2013-2018)
Figure UAE Anticoagulants Sales and Growth Rate (2013-2018)
Figure Egypt Anticoagulants Sales and Growth Rate (2013-2018)
Figure Nigeria Anticoagulants Sales and Growth Rate (2013-2018)
Figure South Africa Anticoagulants Sales and Growth Rate (2013-2018)
Table Global Anticoagulants Sales by Type (2013-2018)
Table Global Anticoagulants Sales Share by Type (2013-2018)
Table Global Anticoagulants Revenue by Type (2013-2018)
Table Global Anticoagulants Revenue Share by Type (2013-2018)
Figure Global Platelet aggregation inhibitors (PAI) Sales Growth (2013-2018)
Figure Global Platelet aggregation inhibitors (PAI) Price (2013-2018)
Figure Global Low-molecular-weight Heparin (LMWH) Sales Growth (2013-2018)
Figure Global Low-molecular-weight Heparin (LMWH) Price (2013-2018)
Figure Global Direct thrombin inhibitor (DTI) Sales Growth (2013-2018)
Figure Global Direct thrombin inhibitor (DTI) Price (2013-2018)
Figure Global Direct factor Xa inhibitors (DFXa) Sales Growth (2013-2018)
Figure Global Direct factor Xa inhibitors (DFXa) Price (2013-2018)
Figure Global Vitamin K antagonists (VKA) Sales Growth (2013-2018)
Figure Global Vitamin K antagonists (VKA) Price (2013-2018)
Figure Global Others Sales Growth (2013-2018)
Figure Global Others Price (2013-2018)
Table Global Anticoagulants Sales by Application (2013-2018)
Table Global Anticoagulants Sales Share by Application (2013-2018)
Figure Global ACS/MI Sales Growth (2013-2018)
Figure Global AF Sales Growth (2013-2018)
Figure Global Other Sales Growth (2013-2018)
Figure Global Anticoagulants Sales, Revenue and Growth Rate (2018-2023)
Table Global Anticoagulants Sales Forecast by Regions (2018-2023)
Table Global Anticoagulants Market Share Forecast by Regions (2018-2023)
Figure North America Sales Anticoagulants Market Forecast (2018-2023)
Figure Europe Sales Anticoagulants Market Forecast (2018-2023)
Figure Asia-Pacific Sales Anticoagulants Market Forecast (2018-2023)
Figure South America Sales Anticoagulants Market Forecast (2018-2023)
Figure Middle East and Africa Sales Anticoagulants Market Forecast (2018-2023)
Table Global Anticoagulants Sales Forecast by Type (2018-2023)
Table Global Anticoagulants Market Share Forecast by Type (2018-2023)
Table Global Anticoagulants Sales Forecast by Application (2018-2023)
Table Global Anticoagulants Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
  • 2018-2023 Global Injectable Anticoagulants Consumption Market Report
    Published: 12-Jul-2018        Price: US 4660 Onwards        Pages: 139
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Injectable Anticoagulants market for 2018-2023. The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin®], enoxaparin [Lovenox®]) and factor Xa inhibitors (fondaparinux [Arixtra®]). In the last several years, global market of injectable anticoagulants developed slowly. In 2016, global revenue of injectabl......
  • 2018 Top 5 Injectable Anticoagulants Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa
    Published: 12-Jul-2018        Price: US 4960 Onwards        Pages: 125
    The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin®], enoxaparin [Lovenox®]) and factor Xa inhibitors (fondaparinux [Arixtra®]). In the last several years, global market of injectable anticoagulants developed slowly. In 2016, global revenue of injectable anticoagulants is nearly 5300 M USD. And the global growth rate is slow. The classification of injectable anticoagulants includes LMWH, DTI and other, and the proportion of LMWH in......
  • 2018-2023 Global Anticoagulants Consumption Market Report
    Published: 12-Jul-2018        Price: US 4660 Onwards        Pages: 162
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Anticoagulants market for 2018-2023. Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some bloo......
  • 2018 Top 5 Anticoagulants Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa
    Published: 12-Jul-2018        Price: US 4960 Onwards        Pages: 143
    Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Anticoagulants Market 2018, Forecast to 2023
    Published: 11-Jul-2018        Price: US 4880 Onwards        Pages: 132
    Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various......
  • Global Injectable Anticoagulants Market by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 11-Jul-2018        Price: US 3480 Onwards        Pages: 128
    The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin®], enoxaparin [Lovenox®]) and factor Xa inhibitors (fondaparinux [Arixtra®]). Scope of the Report: This report focuses on the Injectable Anticoagulants in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. In the last seve......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Injectable Anticoagulants Market 2018, Forecast to 2023
    Published: 11-Jul-2018        Price: US 4880 Onwards        Pages: 137
    The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin®], enoxaparin [Lovenox®]) and factor Xa inhibitors (fondaparinux [Arixtra®]). Scope of the Report: This report focuses on the Injectable Anticoagulants in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. In the last seve......
  • 2018-2023 India Heparin Market Report (Status and Outlook)
    Published: 05-Jul-2018        Price: US 3360 Onwards        Pages: 81
    In 2017, the Heparin market size was xx million USD in India, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. In India market, the top players include - Hepalink - Changshan Pharm - Qianhong Bio-pharma - Opocrin - Pfizer - Aspen Oss - King-friend Biochemical Pharmaceutical - Bioibérica - Dongcheng Biochemicals - Jiulong Biochemicals - Tiandong - Xinbai - Yino......
  • 2018-2023 Philippines Heparin Market Report (Status and Outlook)
    Published: 05-Jul-2018        Price: US 3360 Onwards        Pages: 81
    In 2017, the Heparin market size was xx million USD in Philippines, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. In Philippines market, the top players include - Hepalink - Changshan Pharm - Qianhong Bio-pharma - Opocrin - Pfizer - Aspen Oss - King-friend Biochemical Pharmaceutical - Bioibérica - Dongcheng Biochemicals - Jiulong Biochemicals - Tiandong - Xinbai......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs